Day: February 12, 2026

Austin, TX, Feb. 12, 2026 (GLOBE NEWSWIRE) — Spartacus Acquisition Corp. II (the “Company”) announced today that it closed its initial public offering of 23,000,000 units, at $10.00 per unit, including 3,000,000 units pursuant to the full exercise of the overallotment option by the underwriters. The units began trading on the Nasdaq Capital Market (“Nasdaq”) on Wednesday, February 11, 2026 under the ticker symbol “TMTSU.” Each unit consists of one share of the Company’s Class A ordinary share and one-third of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising...

HOUSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) today announced plans to release 2025 annual results on Wednesday, February 25, 2026, after the market closes. In conjunction with the release, Carriage Services has scheduled a conference call, which will be broadcast live via webcast on Thursday, February 26, 2026, at 8:00 a.m. Central Time.What: Carriage Services 2025 Annual Results Earnings Conference CallWhen: Thursday, February 26, 2026 – 8:00 a.m. Central TimeHow: Live via phone – By dialing 800-330-6710 (Conference ID 3387880) or live via webcast linkClick to Join.   An audio archive of the call will be available on demand via the Company’s website at www.carriageservices.com. Carriage Services is a leading provider of funeral and cemetery services and merchandise in the United...

Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 Company to Host Conference Call with Live Q&A, February 26, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – February 12, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, February 26, 2026.Title:Mdxhealth Presents Fourth Quarter and Full Year 2025 Financial Results andCorporate Update Conference Call and WebcastDate: February 26, 2026Time: 4:30pm ET/ 22:30 CETConference Call Dial-in Details:United States: 1-844-825-9789Int’l: 1-412-317-5180Belgium: 0800 38 961United Kingdom: 0800 279 9489Conference ID:         10206764Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1753070&tp_key=27bce7d4deThe...

New York, NY, Feb. 12, 2026 (GLOBE NEWSWIRE) — D. Boral Acquisition I Corp. (the “Company”) today announced the closing of its initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option, at a price of $10.00 per unit for total gross proceeds of $287,500,000. The units began trading on The Nasdaq Global Market under the ticker symbol “DBCAU” on February 11, 2026. Each unit consists of one of the Company’s Class A ordinary shares and one-half of one redeemable public warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the...

This press release is issued solely to correct a date from an AIM press release dated February 11, 2026. The Subscription Rights will expire if they are not exercised by 5:00 p.m., Eastern Time, on February 27, 2026, the expected expiration date of the Rights Offering. OCALA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of its lead product, Ampligen® (rintatolimod), for the treatment of late-stage pancreatic cancer – a lethal and unmet global health problem – today announced that it has commenced its previously disclosed rights offering (the “Rights Offering”). Pursuant to the Rights Offering, the Company is distributing to all holders of record of the Company’s common stock,...

ROCKVILLE, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report fourth quarter and full year 2025 financial and business results after the market closes on Tuesday, February 24, 2026. Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call to present the fourth quarter and full year 2025 financial and business results on Tuesday, February 24, 2026, at 4:30 p.m. ET. Following management’s prepared remarks and discussion of business results, the call will be open for questions. A live webcast will be accessible in the Events & Presentations section of the Company’s...

DETROIT, Feb. 12, 2026 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) announced that its 2026 Annual Meeting of Stockholders will be Tuesday, May 5. Stockholders of record at the close of business Wednesday, March 11, 2026, are eligible to vote at the meeting. About DT Midstream DT Midstream (NYSE: DTM) is an owner, operator and developer of natural gas interstate and intrastate pipelines, storage and gathering systems, compression, treatment and surface facilities. The company transports clean natural gas for utilities, power plants, marketers, large industrial customers and energy producers across the Southern, Northeastern and Midwestern United States and Canada. The Detroit-based company offers a comprehensive, wellhead-to-market array of services, including natural gas transportation, storage and gathering. For more information,...

NEW YORK — Wix.com Ltd. (Nasdaq: WIX), today announced that it will report its results for the fourth quarter and full year ended December 31, 2025 before the market opens on Wednesday, March 4, 2026. Management will host a conference call and webcast that morning at 8:30 a.m. ET to answer questions about the Company’s financial results. Prior to the conference call and webcast, Wix will issue a press release reporting these results along with a shareholder update and additional materials at https://investors.wix.com/. What: Wix Fourth Quarter and Full Year 2025 Results Conference CallWhen:  Wednesday, March 4, 2026Time: 8:30 a.m. ET Registration:  https://edge.media-server.com/mmc/p/4zs5pwq2 Replay: Replay is available for 12 monthsAbout Wix.com Ltd. Wix is a leading global platform for creating, managing,...